Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
